In a large panel of CRC cell line constitutive basal IGF1R phosphorylation studies, combined with an analysis BI 885578 sensitivity, hyperactivation of the IGF2-driven pathway was only observed in cell lines characterized by IGF2 expression larger than 250 TPM (transcripts per million). The gene discussed is IGF2; the disease is colorectal carcinoma.